Name: Cefuroxime (125mg) + Clavulanic Acid (31.25mg) – Cefuzrom CV Dry Syrup
Brand: Cefuzrom CV Dry Syrup
Rating: 4.8 (150 reviews)

Home/Products /cefuroxime-125mg-clavulanic-acid-31-point-25mg-dry-syrup

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Cefuroxime + Clavulanic Acid Dry Syrup at the best price in PCD Pharma Franchise for Bacterial Infection Treatment

Cefuroxime + Clavulanic Acid Dry Syrup at the best price from tablet manufacturing companies for Bacterial Infection Treatment

Cefuroxime + Clavulanic Acid Dry Syrup at the best price from pharma export companies for Bacterial Infection Treatment

Cefuroxime + Clavulanic Acid Dry Syrup at the best price from the top pharma company for Bacterial Infection Treatment

Cefuzrom CV Dry Syrup at the best price in the Antibiotics Franchise for Bacterial Infection Treatment

Cefuzrom CV Dry Syrup

Composition : Cefuroxime (125mg) + Clavulanic Acid (31.25mg)

Dosage Form : Dry Syrup

Packaging Type :

Packaging :

Price : ₹1/-

Please Contact For Best Price

Cefuzrom CV Dry Syrup is a powerful antibiotic combination of Cefuroxime, a second-generation cephalosporin, and Clavulanic Acid, a beta-lactamase inhibitor. This formulation is designed to treat a variety of bacterial infections by enhancing the effectiveness of Cefuroxime against beta-lactamase-producing organisms, which would otherwise be resistant to antibiotics. Cefuroxime works by interfering with the synthesis of bacterial cell walls, leading to bacterial death, while Clavulanic Acid protects the antibiotic from degradation by bacterial enzymes.

This combination is particularly useful for treating respiratory infections, urinary tract infections (UTIs), skin and soft tissue infections, and infections of the upper respiratory tract, such as otitis media and sinusitis. Cefuzrom CV is also prescribed for community-acquired pneumonia, bronchitis, and infections caused by susceptible strains of E. coli, Streptococcus pneumoniae, and other common bacterial pathogens.